Recombinant DNA (genetic engineering)
Genes are cut and joined into microbes so they make proteins such as human insulin.
Health and medicine · Biotechnology · No. 192
- Digital age
- Readiness 9 of 9
- Process
In 1982 bacteria carrying a human gene became the first source of a biotechnology medicine: human insulin.
Chart: Illustration: Recombinant DNA (genetic engineering)
Where it comes from
Chart: Map of where it comes from
Herbert Boyer and Stanley Cohen met at a meeting on bacterial DNA in Hawaii in 1972. Combining Boyer's DNA-cutting enzyme with Cohen's work on bacterial DNA, their collaboration had its first success in spring 1973.
Three things to know
- Herbert Boyer and Stanley Cohen met at a meeting on bacterial DNA in Hawaii in November 1972 and had their first success in spring 1973.
- Genentech, founded by Boyer and Robert Swanson in 1976, led the first wave of biotechnology firms.
- In 2021 WHO reported that half of the people who need insulin for type 2 diabetes do not get it.
The journey
- 1 GeneA gene for a useful human protein is identified
- 2 JoiningEnzymes cut DNA and join the gene into a carrier
- 3 Host cellThe carrier is placed in a microbe or cultured cell
- 4 ProductionLicensed plants grow the cells, which make the protein
- 5 MedicineThe purified protein is approved and given to patients